Monday, May 29, 2017
 
 
Company News: Page (1) of 1 - 05/17/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
HAMILTON Benefit Performance at SHN Orpheum Theatre Raises Nearly $1 Million for Damon Runyon Cancer Research Foundation
Funds to Support Breakthrough Cancer Research
(May 17, 2017)

SAN FRANCISCO, May 17, 2017 /PRNewswire/ -- The Damon Runyon Cancer Research Foundation hosted a benefit performance of the Broadway musical HAMILTON on Tuesday, May 16, 2017, at the SHN Orpheum Theatre in San Francisco, raising almost $1 million for innovative cancer research. The event attracted notable attendees including: Steve Chen, co-founder of YouTube; Chamath Palihapitiya of Social Capital LP, who is also a part-owner of the Golden State Warriors NBA team and an original member of the Facebook management team; and Mary and Steve Swig, The Swig Co.

"We are thankful to the HAMILTON cast and crew for putting on such a wonderful show benefitting our organization and the funding we provide for cutting-edge cancer research," said Lorraine W. Egan, President and CEO of Damon Runyon. "The Bay Area is a leading incubator for cancer research at Stanford, UCSF, UC Santa Cruz, and UC Berkeley. We've invested over $60 million in Bay Area cancer research programs at these institutions and are confident that the newly raised funds will help expedite our path to the next breakthroughs in cancer research. We also thank the members of our Bay Area Committee who helped promote the event and raise our profile in the Bay Area." 

The Damon Runyon Cancer Research Foundation has enjoyed a long and successful relationship with Broadway. The Foundation was created in 1946 when Walter Winchell went on air with an appeal for contributions to fight cancer in memory of his friend Damon Runyon, a New York writer whose works inspired the hit musical Guys & Dolls. The Damon Runyon Broadway Tickets service was started in the 1950s and it's been vital to the success of the Foundation ever since.


About the Damon Runyon Cancer Research Foundation
To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today's best young scientists with funding to pursue innovative cancer research. The Foundation has invested over $327 million and funded nearly 3,600 young scientists, including 12 Nobel Prize winners. 100% of all donations to the Foundation are used to support scientific research.

Contact: Mahdiyyah Muhammad
JConnelly 
646-838-5445
mmuhammad@jconnelly.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hamilton-benefit-performance-at-shn-orpheum-theatre-raises-nearly-1-million-for-damon-runyon-cancer-research-foundation-300457220.html

SOURCE Damon Runyon Cancer Research Foundation

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Science, Medical, Biology, Cancer,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • Silver Birch of Hammond Affordable Assisted Lifestyle Community Opens Doors
  • Male Infertility Market Size Worth $4.7 Billion by 2025 | CAGR: 4.6%: Grand View Research, Inc.
  • Dental Radiology and Dental Imaging Devices market is expected to grow with CAGR of approximately 10%
  • NetDirector Enables Next-Generation Integration in Radiology with American Health Imaging
  • APR Applied Pharma Research at the 9th ChinaBio® Partnering Forum: Bringing Swiss Made Innovations and Science Driven Technologies to Strengthen Its Presence in the Chinese Market

    Cancer
  • Cone beam computed tomography (CBCT) Systems Market Expected to Reach $1,041 Million, Globally, by 2023 - Allied Market Research
  • Mesothelioma Compensation Center Now Urges the Family of a Person Who Recently Died From Mesothelioma Before They Could Hire a Lawyer to File a Claim to Call for Instant Help
  • Mapi Research Trust Unveils New Clinical Outcome Assessments (COA) Website for the Zarit Burden Interview (ZBI) Questionnaire
  • Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010 - 2017: Deal trends, players, financials and forecasts
  • Artificial Intelligence Firm Set to Revolutionize Healthcare
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines